We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.86B
AUM Growth
+$246M
Cap. Flow
+$82.5M
Cap. Flow %
4.43%
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$7.63M
4
AMZN icon
Amazon
AMZN
+$5.14M
5
TSLA icon
Tesla
TSLA
+$4.94M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$3.11M
2
XOM icon
ExxonMobil
XOM
+$2.53M
3
IMGN
Immunogen Inc
IMGN
+$2.22M
4
CVX icon
Chevron
CVX
+$2.06M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.9%
2 Healthcare 15.37%
3 Consumer Discretionary 12.43%
4 Communication Services 8.94%
5 Energy 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
176
Incyte
INCY
$23.5B
$1.69M 0.09%
27,112
+7,056
+35% +$472K
ARWR icon
177
Arrowhead Research
ARWR
$12.1B
$1.68M 0.09%
47,087
-5,715
-11% -$197K
ELV icon
178
Elevance Health
ELV
$81.9B
$1.68M 0.09%
3,778
+61
+2% +$28.1K
EXPE icon
179
Expedia Group
EXPE
$31.2B
$1.67M 0.09%
15,282
+1,973
+15% +$193K
BPMC
180
DELISTED
Blueprint Medicines
BPMC
$1.67M 0.09%
26,438
-4,162
-14% -$226K
RTX icon
181
RTX Corp
RTX
$287B
$1.67M 0.09%
16,997
+1,349
+9% +$132K
EXEL icon
182
Exelixis
EXEL
$13.9B
$1.66M 0.09%
87,034
+1,782
+2% +$34.3K
PM icon
183
Philip Morris
PM
$301B
$1.65M 0.09%
16,868
+964
+6% +$92.1K
ISEE
184
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.63M 0.09%
41,446
-18,557
-31% -$655K
BBIO icon
185
BridgeBio Pharma
BBIO
$16.5B
$1.62M 0.09%
94,465
+43,692
+86% +$657K
FCX icon
186
Freeport-McMoran
FCX
$90B
$1.62M 0.09%
40,457
+2,109
+5% +$80.4K
RVMD icon
187
Revolution Medicines
RVMD
$40.2B
$1.6M 0.09%
59,708
-1,542
-3% -$37.8K
SYK icon
188
Stryker
SYK
$127B
$1.59M 0.09%
5,210
+139
+3% +$40.1K
ALGN icon
189
Align Technology
ALGN
$12B
$1.59M 0.09%
4,489
+219
+5% +$69.7K
ALKS icon
190
Alkermes
ALKS
$8.82B
$1.59M 0.09%
50,687
+1,054
+2% +$31.9K
EXAS
191
DELISTED
Exact Sciences
EXAS
$1.58M 0.08%
16,796
-3,150
-16% -$246K
WPM icon
192
Wheaton Precious Metals
WPM
$50.6B
$1.57M 0.08%
36,416
-103
-0.3% -$4.89K
NIO icon
193
NIO
NIO
$11.3B
$1.55M 0.08%
160,424
-8,612
-5% -$72.9K
PCVX icon
194
Vaxcyte
PCVX
$7.89B
$1.55M 0.08%
31,004
-3,082
-9% -$146K
VZ icon
195
Verizon
VZ
$194B
$1.54M 0.08%
41,305
+6,801
+20% +$252K
SPGI icon
196
S&P Global
SPGI
$126B
$1.53M 0.08%
3,823
-81
-2% -$29.6K
HZNP
197
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.53M 0.08%
14,861
+3,625
+32% +$382K
TWST icon
198
Twist Bioscience
TWST
$5.62B
$1.53M 0.08%
74,596
-4,863
-6% -$72.8K
FOLD
199
DELISTED
Amicus Therapeutics
FOLD
$1.52M 0.08%
120,729
+7,288
+6% +$86.5K
CMG icon
200
Chipotle Mexican Grill
CMG
$40.8B
$1.51M 0.08%
35,400
+11,400
+48% +$451K
6 7
8
9 10

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Profund Advisors held 1,158 positions worth $1.86B, up 15% from $1.62B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors deployed $82.5M of net new capital in Q2 2023, opening 69 new positions and adding to 498 existing holdings. Its largest new stake was Biomea Fusion: 24,713 shares worth $542K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.11M trimmed.

  • Profund Advisors's largest Q2 2023 buy was Biomea Fusion: 24,713 shares worth $542K.
  • Profund Advisors added most to Apple in Q2 2023, an estimated $12.9M increase.
  • Profund Advisors's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $3.11M.
  • Profund Advisors fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 34% of its $1.86B portfolio in Q2 2023.
  • Profund Advisors opened 69 new positions and closed 91 in Q2 2023.
  • Profund Advisors's portfolio value rose 15% quarter-over-quarter to $1.86B.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.